Advances in treatment of systemic sclerosis.
Herrick
A L
AL
University of Manchester Rheumatic Diseases Centre, Hope Hospital, Salford, UK.
D003520:Cyclophosphamide / Q000627:therapeutic use; D011464:Epoprostenol / Q000627:therapeutic use; D006801:Humans; D016285:Iloprost / Q000627:therapeutic use; D016898:Interferon-alpha / Q000627:therapeutic use; D012595:Scleroderma, Systemic / Q000628:therapy*
D016898:Interferon-alpha; D003520:Cyclophosphamide; D011464:Epoprostenol; D016285:Iloprost